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SGP-2 expression as a genetic marker of progressive cellular pathology
in experimental hydronephrosis. The Onset of hydronephrosis following
unilateral ureteral obstruction is associated with the induced expression
of RNA and proteins encoded by the SGP-2 gene. SGP-2 expression has
been shown to demarcate mammalian cells undergoing apoptosis. Using
in situ hybridization, the cellular localization of SGP-2 expression in the
obstructed kidney was determined as a means to study the various
phases involved in the progression of hydronephrosis. Within 30
minutes of obstruction, SGP-2 mRNA expression was localized to the
adventitial layers of the hilar arteries and intrarenal arterioles. Increas-
ing time of obstruction resulted in the notable absence or depletion of
this layer. In addition, the pattern of SGP-2 expression changed with
time to the collecting ducts and distal tubules. This study identifies the
vascular support tissue of the kidney as the initial site of reaction and
potential cell death following ureteral obstruction. We believe that this
observation may be of importance in explaining the early alterations in
blood flow associated with hydronephrosis.
Complete unilateral ureteral obstruction results in a complex
pattern of pathophysiologic changes in the affected kidney.
Prior studies have elucidated several renal hemodynamic and
humoral alterations associated with the obstructive process.
These include a redistribution of renal blood flow [1], ureteral
and intratubular pressure increases [2, 31, and enhanced pro-
duction of intrarenal hormones [4]. At the cellular level, pro-
longed renal obstruction will result in extensive regions wherein
cells undergo a nonnecrotic cell death histologically character-
ized as apoptosis [5]. The process of cellular apoptosis, also
referred to as a programmed cell death, seems to require the de
novo synthesis of new gene products produced in response to
the noxious stimulus [6—8]. For this reason, apoptosis is con-
sidered to be an active cellular genetic response.
Previously, we had attempted to characterize the gene activ-
ity of obstructive renal pathology by cataloguing gross molec-
ular changes in a rat model of unilateral ureteral obstruction [9].
This study identified a differential pattern of gene activation in
the obstructed kidney compared to the contralateral kidney
beginning within one hour of ureteral obstruction. Many of the
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genes that show enhanced activity during experimental renal
obstruction are also active during rat renal development and
growth [10]. However, the expression of one gene product,
sulfated glycoprotein-2 (SGP-2), previously called testosterone
repressed prostate message-2 (TRPM-2) by our laboratory, was
detected only in the obstructed kidney. Sequence analysis of a
cDNA clone for TRPM-2 isolated from a cDNA library made
from hydronephrotic rat kidney mRNA [111 established homol-
ogy with a gene expressed constitutively by mammalian Sertoli
cells, SGP-2 [12]. Antibody recognition studies confirmed this
homology. Our current genetic cloning data shows that there is
a single genetic unit encoding these two products in the rat [13],
and for this reason we now refer to this product as SGP-2 rather
than TRPM-2. Aside from the hydronephrotic kidney, SGP-2
expression is induced in a variety of other regressing tissues.
This product is synthesized by apoptotic epithelial cells in the
regressing rat prostate gland and in androgen-dependent tumors
following hormonal ablation. We have detected its synthesis by
renal cells following ischemialreperfusion injury or bladder
tumor cells following cytotoxic chemotherapy [14, 15]. Even
embryonic cells express SGP-2 gene products as they die in
response to developmental signals. In each of these systems
SGP-2 expression is restricted to specified cell types that are
about to undergo apoptosis. Therefore, despite the fact that
SGP-2 has several constituitive sites of expression in the rat, its
highly induced synthesis in apoptotic cells of regressing tissues
implies that this product plays some role in the pathway of
apoptotic cell death. More important, it provides a convenient
marker to identify the occurence of apoptosis and certain types
of cellular pathology in these types of tissues.
In our earlier study of hydronephrosis in the rat, expression
of the SGP-2 transcript peaked at 48 hours after ureteral ligation
by a Northern blot analysis [9, 141. In situ hybridization of a 48
hour hydronephrotic kidney identified the epithelial cells of the
distal tubules and collecting ducts as the source of the SGP-2
[14]. In this study, we present an analysis of earlier time points
following ureteral obstruction to determine whether this genetic
marker of apoptosis might distinguish pathologic changes in any
other renal cell type following obstructive injury. The results of
this analysis lead us to propose a pathway of progressive renal
cellular pathology leading to the development of hydronephrosis.
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Methods
Animals
Male Sprague-Dawley rats weighing 200 to 250 grams (Camm
Industries, Wayne, New Jersey, USA) underwent complete left
ureteral obstruction with a silk ligature under sodium pentobar-
bitol anesthesia. Rats were sacrificed with a lethal dose of
sodium pentobarbital and both the obstructed and contralateral
kidneys were removed at 30 minutes, 24, 48, 144 and 336 hours
post-obstruction. Kidneys from normal and sham operated
rodents served as control tissues.
In situ hybridization
Bisected kidneys were fixed overnight at 4°C in a solution
containing 4% paraformaldehyde, 10 m phosphate buffer, pH
7.5 and 0.15 M NaC1 with gentle agitation [14]. The tissue was
dehydrated in graded alcohols and prepared for sectioning in
paraffin blocks. Six micron sections were cut from the paraffin
block with a microtome and fixed on poly-L-lysine coated glass
slides by baking at 40°C for 24 hours and 60°C for three hours.
Prior to hybridization, tissue sections were rehydrated using
graded alcohols and incubated with proteinase K (I ,ag/ml) to
access cellular RNA. The sections were prehybridized for four
hours at 50°C with a solution containing 50% formamide, I x
Denhardt's solution (0.5% Ficoll, 0.5% polyvinylpyrrolidine,
0.5% bovine serum albumin), 10% dextran sulfate, 10 mrvi
dithiothreitol, 0.6 M NaCI, 10 m Na phosphate, 1 mivi EDTA.
yeast tRNA (50 g/ml) and denatured salmon sperm DNA (50
g!ml). Hybridization was then performed overnight at 50°C
after exchanging the prehybridization buffer for the hybridiza-
tion buffer (as above) containing the 35S radiolabelled RNA
probe (300 ng/ml) for SGP-2.
RNA probes were prepared from the T7/SP6 expression
vector (pGEM-vector, Promega) containing a partial cDNA
insert for SGP-2 (PG2I-04) [161 inserted between the T7 and
SP6 RNA polymerase promoter sites. In vitro transcription was
performed on a linearized plasmid in a solution containing 50
mM Tris hydrochloride (pH 7.9); 6 mivi MgCI2: 2 mM spermi-
dine; 10 mri NaCI; 10 ms'i dithiothreitol; 0.5 mivi ATP, 0.5 mM
CTP and 0.5 msi GTP for one hour at 37°C with SP6 polymerase
or at 42°C with T7 polymerase (Promega Biotec, Madison,
Wisconsin, USA) in the presence of 1.2 jsM (35S)UTP (Amer-
sham Corp., Arlington Heights, Illinois. USA) and 1,000 U of
RNasin per ml. Labeled RNA transcripts were then phenol-
chloroform extracted (1:1) and ethanol precipitated.
Following hybridization, slides were washed in 2 x SSC (1 x
SSC = 0.15 M NaCl/0.15 M Na citrate) at 55°C for 30 minutes
and then incubated in 2 x SSC containing 50 g/ml of pancre-
atic RNase. Then, slides were washed in decreasing concentra-
tions of SSC (from 2 x to 0.1 x) containing 0.1% sodium
thiosulfate and 0.1% sodium pyrophosphate for 30 minute
periods. Slides were then dehydrated and coated with NBT-2
autoradiographic emulsion (Eastman Kodak Co., Rochester,
New York, USA). Coated slides were exposed at 4°C and at
various times were developed by standard techniques and
stained with hematoxylin and eosin.
Results
Prior Northern blot analysis of obstructed rat kidneys re-
vealed the presence of transcripts encoded by SGP-2 within 10
hours of ureteral obstruction. Although SGP-2 transcripts were
not detected by Northern blot analysis prior to 10 hours, our in
situ hybridization experiments revealed that SGP-2 mRNA was
expressed in very distinct regions of the obstructed kidney as
early as 30 minutes after ureteral ligation. At this time point
(Fig. I) intense labeling of the adventitial layer of the hilar
arteries as well as that of the intrarenal arterioles and interlob-
ular arteries was seen. Expression was also evident in the
urothelial submucosa of the renal pelvis and in hilar adipose
tissue adjacent to the pelvic musculature. The cortical tubules
did not express SGP-2 mRNA at 30 minutes, while only rare
collecting tubules showed expression.
In sections obtained from 24-hour obstructed kidneys the
pattern of SGP-2 expression was dramatically changed (Fig. 2).
SGP-2 transcripts were no longer evident in the perivascular
regions or the renal pelvis. Labeling at this time point was most
intense over a majority of the epithelial cells of the collecting
tubules and distal tubules whose lumens appeared slightly
dilated with flattened epithelium. Early coagulation necrosis of
the papillary tip as well as calyceal dilatation were evident at
this time.
By 48 hours, an intense expression of SGP-2 was seen over
both the distal and collecting tubules which now were clearly
dilated (Fig. 3). Although the majority of distal and collecting
tubules expressed SGP-2 at this time, there were scattered,
isolated tubules which did not. The tubules which did not
express SGP-2 also did not appear to be dilated or flattened. At
six days post-obstruction, histological changes consistent with
renal obstruction were clearly evident. These changes included
necrosis of the papillae with polymorphonuclear reaction,
patchy interstitial inflammation of the cortex and medulla,
polymorphonuclear casts as well as mild dilatation of the
proximal tubules. SGP-2 expression (Fig. 4) persisted over the
dilated collecting and distal tubules albeit to a much lesser
degree than noted at 24 or 48 hours. In certain areas which had
previously expressed SGP-2 it was observed that there was a
distinct change in the tissue appearance. The layer of pelvic
submucosal and adventitial connective tissue was clearly ab-
sent or severely decreased as was the perivascular connective
tissue of the hilar vessels (Fig. 5). Throughout the cortex there
was an apparent reduction in the number of interlobular arteries
and arterioles compared to controls.
At two weeks, the obstructed kidney revealed chronic his-
tologic changes typical of hydronephrosis. Only occasional,
seemingly intact, distal tubules expressed SGP-2 while proxi-
mal tubules showed equivocal focal expression. At no time
point analyzed did glomeruli show evidence of SGP-2 expres-
sion. SGP-2 expression was not seen at any time point in
normal, contralateral or sham operated kidney. Obstructed or
sham operated kidneys showed no hybridization to the sense
probe (Fig. 6).
Discussion
The ultimate fate of renal cells in unrelieved ureteral obstruc-
tion is to undergo apoptosis [5]. The early induction of gene
transcripts prior to apoptotic death has been analyzed both in
the kidney and in other organs and, paradoxically, appears to be
similar to that of cells responding to proliferative stimuli [9, 17].
It may be that early gene activation in various different cellular
processes (growth, death) is similar in an initiation phase
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Fig. 1. SGP-2 expression in the kidney following 30 minutes of ureteral obstruction. Longitudinal sections were taken of rat kidneys and
hybridized to a 355-labeled antisense probe for SGP-2. Representative light (left column) and dark (right column) field exposures reveal: (A) SGP-2
expression in the urothelial submucosal region of the renal pelvis and hilar adipose tissue; (B) SGP-2 expression in the adventitial regions of the
hilar arteries; and (C) intense labeling of the adventitial layer of an intrarenal arteriole with SGP-2 (X 100).
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Fig. 4. SGP-2 expression can still be seen 6 days post-obstruction over
medullary collecting tubules (X 250).
Fig. 2. Following 24 hours of ureteral obstruction SGP-2 expression is
seen over the (A) distal tubules and (B) medullary collecting ducts
(x 250).
Fig. 5. Six days post-obstruction the perivascular connective tissue of
the hilar vessels is absent. This is the region of earlier SGP-2 expression
(x 250).
In this study we defined the renal cells expressing SGP-2 as a
function of time after unilateral ureteral obstruction. We ini-
tially detected SGP-2 expression (within 30 minutes of ureteral
obstruction) in the adventitial layers of the renal pelvis, main
renal blood vessels and intrarenal arteries. The observation that
these tissues are depleted or deleted at six days in hydrone-
phrotic kidneys would indicate that the expression of SGP-2
preceeds cellular death. Cast studies of the renal microvascu-
lature following 14 days of obstruction have demonstrated renal
segmental arterial constriction as well as decreased density of
blood vessels, especially in the cortex [18]. The expression of
SGP-2 in the renal vasculature suggests that apoptosis plays a
Fig. 3. An intense expression of SGP-2 is evident over the distal role in the eventual ischemic events responsible for renal
tubules 48 hours after obstruction (X 250). damage following complete obstruction.
Early obstruction results in primarily distal tubular dysfunc-
(c-fos>c-myc>hsp-70). At some point, the genetic response tion. The marked expression of SGP-2 in the renal medulla at 24
pathways diverge with novel RNA and proteins produced and 48 hours may result from the significant decrease in renal
during cell death, an example of which is SGP-2. blood flow to the entire kidney and in particular to the medulla.
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Fig. 6. Thirty-minute sham operated, obstructed and contralateral kidney served as controls. (A) Sham operated kidney and (B) contralateral
kidney probed with the 355-labeled SGP-2 antisense probe. 355-labeled sense probe for SGP-2 in the obstructed kidney both light (Cl) and dark
(C2) field exposures (x 100).
The cells of the glomerulus and proximal tubules did not
express SGP-2 at the time points studied in this experiment, and
this is consistent with the known relative sparing of these cells
from the ischemic insult within the first two weeks [19, 201. It
may be that the proximal tubules and glomeruli are relatively
spared an ischemic insult since the cortical circulation receives
90% of the total renal blood flow and at higher pressures than
the medulla. An alternative explanation is that if SGP-2 was
only transiently expressed we simply did not study a time point
during which it was induced, or perhaps it was induced at a
point beyond two weeks of obstruction.
Whether SGP-2 expression is the cause or result of the
genetic process of cell death is unknown at this time. However,
as we have shown here, its expression during cell injury makes
it an interesting marker to study the progression of renal disease
states.
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